Skip to Content
Merck
CN

Key Documents

View All Documentation

194824

Borane dimethyl sulfide complex solution

2.0 M in toluene

Synonym(s):

BMS, Trihydro[thiobis[methane]]boron

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
(CH3)2S · BH3
CAS Number:
13292-87-0
Molecular Weight:
75.97
PubChem Substance ID:
24851335
UNSPSC Code:
12352112
Beilstein/REAXYS Number:
3663489
MDL number:
MFCD00013189
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

reaction suitability

reagent type: reductant

concentration

2.0 M in toluene

density

0.856 g/mL at 25 °C

SMILES string

B.CSC

InChI

1S/C2H6S.BH3/c1-3-2;/h1-2H3;1H3

InChI key

RMHDLBZYPISZOI-UHFFFAOYSA-N

Application

Reactant used as a regioselective reducing agent

Reactant involved in:
  • Hydroboration / oxidation
Synthesis of cage compounds

Still not finding the right product?

Explore all of our products under Borane dimethyl sulfide complex solution

signalword

Danger

target_organs

Central nervous system

supp_hazards

EUH014

Storage Class

4.3 - Hazardous materials which set free flammable gases upon contact with water

wgk

WGK 3

flash_point_f

44.6 °F - closed cup

flash_point_c

7 °C - closed cup

ppe

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Oral - Aquatic Chronic 3 - Asp. Tox. 1 - Eye Dam. 1 - Flam. Liq. 2 - Repr. 1B - Skin Irrit. 2 - STOT RE 2 - STOT SE 3 - Water-react. 1

Regulatory Information

新产品

This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
61496TM
09996HJ
S46238
04806TH
S44928

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

A Burchert et al.
Leukemia, 29(6), 1331-1335 (2015-02-26)
A minority of chronic myeloid leukemia (CML) patients is capable of successfully discontinuing imatinib. Treatment modalities to increase this proportion are currently unknown. Here, we assessed the role of interferon alpha 2a (IFN) on therapy discontinuation in a previously reported
Andrew J Saykin et al.
Alzheimer's & dementia : the journal of the Alzheimer's Association, 11(7), 792-814 (2015-07-22)
Genetic data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) have been crucial in advancing the understanding of Alzheimer's disease (AD) pathophysiology. Here, we provide an update on sample collection, scientific progress and opportunities, conceptual issues, and future plans. Lymphoblastoid cell
Kathleen C Rollet-Kurhajec et al.
PloS one, 10(6), e0129868-e0129868 (2015-06-20)
In Hepatitis C virus (HCV) mono-infection, male sex is associated with faster liver fibrosis progression but the effects of sex have not been well studied in HIV-HCV co-infected patients. We examined the influence of sex on progression to significant liver
View All Related Papers